We are live on ! Find out more
Nicholas Company

Nicholas Company Portfolio holdings

AUM $5.47B Turnover 6.8%
1-Year Est. Return 16.96%
This Fund
S&P 500
This Quarter Est. Return
+3.14%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$5.35B
AUM Growth
+$68.6M
Cap. Flow
+$11.9M
Cap. Flow %
0.22%
Top 10 Hldgs %
28.82%
Holding
225
New
11
Increased
66
Reduced
54
Closed
15
Avg Time Held
1.9 years
Top 10 Avg Time Held
1.8 years
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$123M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$33.5M
3
PARA icon
Paramount Global Class B
PARA
+$32.1M
4
BHC icon
Bausch Health
BHC
+$24.1M
5
PFE icon
Pfizer
PFE
+$21M

Top Sells

Rank Stock Value
1
KMI icon
Kinder Morgan
KMI
+$91.8M
2
MCD icon
McDonald's
MCD
+$82.7M
3
CAB
Cabela's Inc
CAB
+$64.2M
4
ORCL icon
Oracle
ORCL
+$43.2M
5
MSFT icon
Microsoft
MSFT
+$41.6M

Sector Composition

Rank Sector Weight
1 Healthcare 28.05%
2 Industrials 19.5%
3 Consumer Discretionary 14.62%
4 Financials 11.15%
5 Communication Services 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
GILD icon
1
Gilead Sciences
GILD
$195B
$207M 3.87%
2,045,492
-49,033
-2% -$5.1M
2013 Q2
10 quarters
WBA icon
2
DELISTED
Walgreens Boots Alliance
WBA
$194M 3.62%
2,272,425
+29,000
+1% +$2.46M
2013 Q2
10 quarters
BHC icon
3
Bausch Health
BHC
$2.36B
$161M 3.02%
1,586,925
+214,435
+16% +$24.1M
2013 Q2
10 quarters
SNA icon
4
Snap-on
SNA
$18.9B
$149M 2.79%
870,860
-69,315
-7% -$11.5M
2013 Q2
10 quarters
TMO icon
5
Thermo Fisher Scientific
TMO
$258B
$148M 2.77%
1,045,489
+31,830
+3% +$4.25M
2013 Q2
10 quarters
AMG icon
6
Affiliated Managers Group
AMG
$9.91B
$147M 2.74%
918,420
+81,360
+10% +$14M
2013 Q2
10 quarters
LKQ icon
7
LKQ Corp
LKQ
$5.66B
$138M 2.59%
4,669,987
+134,580
+3% +$3.91M
2013 Q2
10 quarters
CB icon
8
Chubb
CB
$136B
$136M 2.54%
1,161,135
+39,145
+3% +$4.43M
2014 Q1
7 quarters
T icon
9
AT&T
T
$161B
$134M 2.5%
5,138,159
+327,425
+7% +$8.31M
2013 Q2
10 quarters
ORLY icon
10
O'Reilly Automotive
ORLY
$71.6B
$127M 2.38%
7,544,430
-1,642,425
-18% -$28.5M
2013 Q2
10 quarters
AON icon
11
Aon
AON
$60.8B
$126M 2.36%
1,370,680
+42,590
+3% +$3.97M
2013 Q2
10 quarters
UHAL icon
12
U-Haul Holding Co
UHAL
$11.2B
$125M 2.33%
3,203,760
+64,890
+2% +$2.62M
2014 Q2
6 quarters
IBM icon
13
IBM
IBM
$221B
$121M 2.26%
+918,969
New +$123M
2015 Q4
0 quarters
PFE icon
14
Pfizer
PFE
$168B
$116M 2.16%
3,772,777
+667,951
+22% +$21M
2013 Q2
10 quarters
ADT icon
15
DELISTED
ADT Corp
ADT
$115M 2.15%
3,483,625
-201,105
-5% -$6.77M
2014 Q2
6 quarters
TWX
16
DELISTED
Time Warner Inc
TWX
$114M 2.13%
1,763,070
+55,760
+3% +$3.9M
2013 Q2
10 quarters
BALL icon
17
Ball Corp
BALL
$16.6B
$113M 2.11%
3,108,092
+104,960
+3% +$3.59M
2013 Q2
10 quarters
PM icon
18
Philip Morris
PM
$312B
$106M 1.99%
1,207,605
+35,000
+3% +$3.04M
2013 Q2
10 quarters
CBRE icon
19
CBRE Group
CBRE
$39.2B
$106M 1.98%
3,065,140
+80,555
+3% +$2.84M
2013 Q2
10 quarters
ABBV icon
20
AbbVie
ABBV
$501B
$106M 1.98%
1,782,850
+53,680
+3% +$3.09M
2015 Q1
3 quarters
DVA icon
21
DaVita
DVA
$12.1B
$102M 1.9%
1,458,878
+206,325
+16% +$15.1M
2013 Q2
10 quarters
JCI icon
22
Johnson Controls International
JCI
$89.4B
$101M 1.88%
2,436,979
+180,562
+8% +$8.17M
2013 Q4
8 quarters
JAZZ icon
23
Jazz Pharmaceuticals
JAZZ
$13.9B
$94.9M 1.78%
675,230
+241,605
+56% +$33.5M
2013 Q3
9 quarters
TGNA icon
24
DELISTED
TEGNA Inc
TGNA
$93.8M 1.75%
5,744,969
+168,688
+3% +$2.85M
2013 Q2
10 quarters
MSFT icon
25
Microsoft
MSFT
$4.01T
$93.5M 1.75%
1,686,010
-790,435
-32% -$41.6M
2013 Q2
10 quarters
1
2 3 4 5

Similar funds

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EFG International
EFG International Zurich $5.46B AUM
Antipodes Partners
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Exor N.V.
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Voleon Capital Management
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
Glenview Capital Management
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TD Private Client Wealth
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Nicholas Company's Q4 2015 Portfolio in Review

As of Q4 2015, Nicholas Company held 225 positions worth $5.35B, up 1.3% from $5.28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Nicholas Company's Q4 2015 filing shows 11 new, 66 increased, 54 reduced and 15 closed positions. Its largest new stake was IBM: 918,969 shares worth $121M. The largest sale was Kinder Morgan, an estimated $91.8M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Nicholas Company's largest Q4 2015 buy was IBM: 918,969 shares worth $121M.
  • Nicholas Company added most to Jazz Pharmaceuticals in Q4 2015, an estimated $33.5M increase.
  • Nicholas Company's biggest Q4 2015 reduction was Kinder Morgan, cutting an estimated $91.8M.
  • Nicholas Company fully exited Cabela's Inc in Q4 2015, selling an estimated $64.2M.
  • Nicholas Company's ten largest holdings make up 29% of its $5.35B portfolio in Q4 2015.
  • Nicholas Company opened 11 new positions and closed 15 in Q4 2015.
  • Nicholas Company's portfolio value rose 1.3% quarter-over-quarter to $5.35B.

Based on Nicholas Company's 13F filing for Q4 2015, filed 11 Feb 2016.